Feasibility Testing a Decision-support Intervention for Clinical Trials

Trial Title: Feasibility Testing a Decision-support Intervention for Clinical Trials

NCT ID: NCT06291610

Condition: Head and Neck Neoplasms

Conditions: Official terms:
Head and Neck Neoplasms

Conditions: Keywords:
Clinical trial decision making
Patient involvement
Decision coaching
Feasibility study
Complex intervention

Study type: Interventional

Study phase: N/A

Overall status: Recruiting

Study design:

Allocation: N/A

Intervention model: Single Group Assignment

Intervention model description: Pre- and post-intervention measures in two consecutive groups.

Primary purpose: Health Services Research

Masking: None (Open Label)

Masking description: Patients are recruited anonymous

Intervention:

Intervention type: Behavioral
Intervention name: Clinical trial decision support intervention
Description: 1. a patient decision aid tailored to clinical trial participation 2. decision coaching consultations carried out by trained healthcare professionals. 3. a training program in decision coaching will be an integrated part of the intervention.
Arm group label: Decision intervention group

Summary: A decision-support intervention are developed for a Danish nationwide randomised controlled trial (RCT) among patients with laryngeal and pharyngeal cancer referred to curative intended radiotherapy. The primary endpoints in this RCT are levels of dysphagia and xerostomia. The decision-support intervention consists of three components, including (1) a patient decision aid tailored to clinical trial participation and (2) decision coaching consultations carried out by trained healthcare professionals. Finally, (3) a training program in decision coaching will be an integrated part of the intervention. To feasibility test (beta test) the intervention, 60 patient participants will be included, separated into pre- (n=30) and post- (n=30) intervention groups. Pre-intervention to complete the survey based on current clinical practice. Post-intervention to complete the survey following engagement in the decision support intervention. A total of 12 physicians will be recruited and trained in decision coaching. To assess the acceptability of the intervention, the physicians will be interviewed. Additionally, they will be asked to audio-record two decision coaching sessions to test the fidelity of the intervention.

Detailed description: Decision-support interventions for patients considering clinical trial participation may promote informed decisions. However, decision interventions for people considering clinical trial participation are still limited. This study aims to develop and test the acceptability and feasibility of a decision-support intervention to enhance informed decision-making regarding clinical trial participation. A decision-support intervention has been developed for a Danish nationwide randomised controlled trial (RCT) among patients with laryngeal and pharyngeal cancer referred to curative intended radiotherapy. The primary endpoints in this RCT are levels of dysphagia and xerostomia. The decision-support intervention consists of three components, including (1) a patient decision aid tailored to clinical trial participation and (2) decision coaching consultations carried out by trained healthcare professionals. Finally, (3) a training program in decision coaching will be an integrated part of the intervention. To feasibility test (beta test) the intervention, 60 patient participants will be included, separated into pre- (n=30) and post- (n=30) intervention groups. Pre-intervention to complete the survey based on current clinical practice. Post-intervention to complete the survey following engagement in the decision support intervention. A total of 12 physicians will be recruited and trained in decision coaching. To assess the acceptability of the intervention, the physicians will be interviewed. Additionally, they will be asked to audio-record two decision coaching sessions to test the fidelity of the intervention. Methods: Patient participants outcome ( questionnaire survey) 1. The stages of decision making measure (self translated forward/backward) 2. Decisional conflict scale 3. The decision preparation scale (post intervention measure) 4. Items on health literacy related to the specific context (understanding the trial, the treatment modalities, practical issues, etc.) 5. Decision preference The interviews with the clinicians (decision coaches) will follow the interpretive description methodology and be conducted as qualitative, semi-structured audio-recorded interviews. The interviews will be carried out on the telephone. The quantitative data will be hosted, organised, and analysed in STATA. The qualitative data will be hosted, organised, and analysed in a software system called NVivo. To evaluate the impact of the decision-support intervention, it is necessary to assess the extent to which it is used as intended in clinical practice. This is referred to as a fidelity test. Hence, the decision coaches will be provided with dictaphones and asked to audio-record the consultations. The audio records will be evaluated using the Decision Support Analysis Tool (DSAT-10), which is a tool to assess practitioners' use of decision support and communication skills during a clinical encounter. Further studies Building upon the current study, the potential for further development, implementation and evaluation across proton therapy clinical trials will be determined. Assessing a decision support intervention for trial participation in a single host trial is challenging due to the limited period of the host trial and insufficient statistical power for comparative tests. Additional intervention development could involve establishing an online decision support intervention platform for Danish proton therapy clinical trials and a training platform in decision coaching for healthcare professionals. Moreover, integrating measurements (decisional conflict, etc.) as active pro measures to identify decisional needs during decisional coaching could be explored. A cluster randomised trial is the most suitable approach for full-scale implementation and evaluation.

Criteria for eligibility:
Criteria:
Inclusion Criteria: - Patients with cancer of the pharynx or larynx - Received verbal information regarding DAHANCA 35 - Read the patient information folder from DAHANCA 35 - Above 18 years - Danish speaking Exclusion Criteria: - Dyslexia

Gender: All

Minimum age: 18 Years

Maximum age: N/A

Healthy volunteers: No

Locations:

Facility:
Name: Aarhus University Hospital

Address:
City: Aarhus
Zip: 8200
Country: Denmark

Status: Recruiting

Contact:
Last name: Anne Kristensen

Phone: +4530315605
Email: annkrs@rm.dk

Contact backup:
Last name: Cai Grau
Email: cai.grau@rm.dk

Start date: February 19, 2024

Completion date: December 31, 2026

Lead sponsor:
Agency: University of Aarhus
Agency class: Other

Source: University of Aarhus

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT06291610